Coloplast A/S (CO:COLO-B) — Stock Price

Dkr429.20 DKK
▼ -1.90% today

Coloplast A/S (CO:COLO-B) is currently trading at Dkr429.20 DKK, down 1.90% today. Over the past 52 weeks, shares have ranged between Dkr372.30 and Dkr630.60. This page tracks Coloplast A/S's live share price on the CO exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see COLO-B stock market capitalisation.

Coloplast A/S (COLO-B) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Coloplast A/S's daily closing share price and trading volume on the CO exchange over the past year, giving a clear view of recent price momentum and liquidity.

Coloplast A/S Income Statement — Revenue, Profit & Earnings by Year

Coloplast A/S's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue Dkr27.87 Billion Dkr27.03 Billion Dkr24.50 Billion Dkr22.58 Billion Dkr19.43 Billion
Cost of Revenue Dkr9.74 Billion Dkr8.76 Billion Dkr8.17 Billion Dkr7.05 Billion Dkr6.11 Billion
Gross Profit Dkr18.14 Billion Dkr18.27 Billion Dkr16.33 Billion Dkr15.53 Billion Dkr13.31 Billion
Research & Development Dkr900.00 Million Dkr866.00 Million Dkr872.00 Million Dkr866.00 Million Dkr755.00 Million
SG&A — Dkr1.24 Billion Dkr1.11 Billion Dkr1.00 Billion Dkr762.00 Million
Total Operating Expenses Dkr10.56 Billion Dkr10.95 Billion Dkr9.48 Billion Dkr8.62 Billion Dkr6.96 Billion
Operating Income Dkr7.58 Billion Dkr7.32 Billion Dkr6.77 Billion Dkr6.44 Billion Dkr6.36 Billion
EBITDA Dkr8.34 Billion Dkr8.57 Billion Dkr7.73 Billion Dkr7.23 Billion Dkr7.08 Billion
EBIT Dkr6.98 Billion Dkr7.28 Billion Dkr6.66 Billion Dkr6.30 Billion Dkr6.29 Billion
Interest Expense Dkr825.00 Million Dkr882.00 Million Dkr719.00 Million Dkr240.00 Million Dkr57.00 Million
Income Before Tax Dkr6.16 Billion Dkr6.39 Billion Dkr6.03 Billion Dkr6.13 Billion Dkr6.23 Billion
Income Tax Expense Dkr2.52 Billion Dkr1.34 Billion Dkr1.24 Billion Dkr1.42 Billion Dkr1.41 Billion
Net Income Dkr3.64 Billion Dkr5.05 Billion Dkr4.78 Billion Dkr4.71 Billion Dkr4.83 Billion

Coloplast A/S Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Coloplast A/S's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets Dkr48.37 Billion Dkr48.07 Billion Dkr48.16 Billion Dkr34.96 Billion Dkr15.84 Billion
Total Current Assets Dkr10.45 Billion Dkr10.44 Billion Dkr9.94 Billion Dkr8.77 Billion Dkr6.99 Billion
Cash & Equivalents — — — — —
Short-term Investments — — Dkr-39.00 Million Dkr219.00 Million Dkr226.00 Million
Net Receivables Dkr5.18 Billion Dkr5.04 Billion Dkr4.59 Billion Dkr4.32 Billion Dkr3.44 Billion
Inventory Dkr3.92 Billion Dkr3.67 Billion Dkr3.52 Billion Dkr3.19 Billion Dkr2.43 Billion
Property, Plant & Equipment — — — Dkr4.13 Billion Dkr3.58 Billion
Goodwill Dkr19.33 Billion Dkr19.38 Billion Dkr19.97 Billion Dkr11.81 Billion Dkr2.03 Billion
Total Liabilities Dkr32.24 Billion Dkr30.13 Billion Dkr30.86 Billion Dkr26.66 Billion Dkr7.67 Billion
Total Current Liabilities Dkr6.50 Billion Dkr10.20 Billion Dkr16.31 Billion Dkr7.34 Billion Dkr6.31 Billion
Long-term Debt — Dkr16.56 Billion Dkr11.56 Billion Dkr16.36 Billion Dkr0.00
Net Debt Dkr21.69 Billion Dkr21.84 Billion Dkr18.66 Billion Dkr18.29 Billion Dkr2.34 Billion
Total Stockholder Equity Dkr16.12 Billion Dkr17.94 Billion Dkr17.30 Billion Dkr8.29 Billion Dkr8.17 Billion
Retained Earnings Dkr17.68 Billion Dkr15.39 Billion Dkr14.63 Billion Dkr5.39 Billion Dkr5.41 Billion

Coloplast A/S Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Coloplast A/S generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow Dkr6.64 Billion Dkr2.77 Billion Dkr4.23 Billion Dkr5.10 Billion Dkr5.29 Billion
Capital Expenditures Dkr1.31 Billion Dkr1.17 Billion Dkr1.24 Billion Dkr1.14 Billion Dkr1.97 Billion
Free Cash Flow Dkr5.34 Billion Dkr1.60 Billion Dkr2.98 Billion Dkr3.96 Billion Dkr3.32 Billion
Investing Cash Flow Dkr-1.25 Billion Dkr-1.34 Billion Dkr-8.96 Billion Dkr-11.76 Billion Dkr-2.01 Billion
Financing Cash Flow Dkr-5.19 Billion Dkr-1.52 Billion Dkr5.26 Billion Dkr6.59 Billion Dkr-3.18 Billion
Dividends Paid Dkr4.96 Billion Dkr4.72 Billion Dkr4.25 Billion Dkr4.04 Billion Dkr3.83 Billion
Stock-Based Compensation — — Dkr57.00 Million Dkr49.00 Million Dkr53.00 Million
Depreciation Dkr1.35 Billion Dkr1.29 Billion Dkr1.07 Billion Dkr930.00 Million Dkr792.00 Million
Change in Cash Dkr159.00 Million Dkr-123.00 Million Dkr534.00 Million Dkr-34.00 Million Dkr125.00 Million

Coloplast A/S Earnings History — EPS Actual vs. Analyst Estimates

Track Coloplast A/S's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
May 12, 2026 — 5.95 —
Feb 06, 2026 6.32 6.07 +4.12%
Nov 04, 2025 3.88 5.81 -33.22%
Aug 19, 2025 4.93 5.25 -6.10%
May 06, 2025 5.45 5.94 -8.25%
Feb 04, 2025 6.38 5.76 +10.76%
Nov 05, 2024 5.47 5.82 -6.01%
Aug 20, 2024 5.79 6.03 -3.98%